# Ernexa Therapeutics Inc.: Form 8-K, filed Dec 21, 2021

- Company: [Ernexa Therapeutics Inc.](/companies/erna.md) (CIK 748592)
- Form: 8-K
- Filed: 2021-12-21
- Accepted by EDGAR: Dec 21, 2021, 16:30 ET
- Period: 2021-12-16
- Accession: 0001140361-21-042603
- Inline XBRL: yes
- Main document: https://www.sec.gov/Archives/edgar/data/748592/000114036121042603/brhc10032107_8k.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/748592/000114036121042603/

## Items reported

- Item 5.02: Departure or appointment of officers or directors

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/748592/000114036121042603/brhc10032107_8k.htm

Filed Dec 21, 2021.
Source: SEC EDGAR, the filing index for accession 0001140361-21-042603. Last ingested by Listed: Nov 11, 2026, 02:49 ET. No prices; not investment advice.